CHO Cell Line

Characterization Testing for
CHO Cell Banks

Recommended Testing Panel for CHO Cell Banks

Robust cell line characterization ensures the safety, quality, and consistency of biopharmaceutical products manufactured using CHO (Chinese Hamster Ovary) cells. A well-defined testing strategy across the cell banking lifecycle—from Master Cell Bank (MCB) to Working Cell Bank (WCB) and End-of-Production Cells (EOP)—is essential to demonstrate cell line identity, purity, genetic stability, and freedom from adventitious agents.

This flyer outlines the recommended testing panel at each stage of cell banking based on regulatory expectations and industry best practices. The testing strategy is designed to ensure that cell substrates remain suitable, stable, and compliant throughout their intended use and therefore support manufacture of a consistent product with respect to quality, potency and efficacy.

Full Assay Name
MCB
WCB
EOP
Test Code
Minimum Sample Requirements
TAT (days)
Safety
Isolator Sterility Testing by Direct Inoculation USP<71> (GMP) – (Up to 100mL TA or 20 Vials)
✅
✅
✅
3000004994
Per USP guidelines
21
Bacteriostasis and Fungistasis (Direct Method) (GMP)1
✅
✅
3000004996
Varies depending on fill/volume
21
EP, JP, and USP Mycoplasma Detection (GMP)
✅
✅
✅
3000005147
1x15mL & 1e6 cells/mL
35
EP, JP, and USP Mycoplasma Detection with Mycoplasmastasis (GMP)
✅
✅
3000007121
1x45mL & 1e6 cells/mL
35
Mycobacterium Tuberculosis DNA Detection by qPCR (GMP)
✅
✅
3000005638
1e7 cells frozen
9
In Vitro Assay for Adventitious Virus Contaminants – MRC-5, VERO, and CHO Cells with Hemadsorption and Hemagglutination Endpoints (GMP) – Extended Duration
✅
✅
✅
3000005092
2x6mL at 1e7 cells/mL
35
AgentSCREEN™ Adventitious Virus Detection in Cell Bank Sample by NGS (GMP)
✅
✅
3000008512
>5e6 cells/mL
28
Co-Cultivation of Test Article Cells with *Mus dunni* Cells and PG4 S+L– Endpoint – 2 Passes (GMP)
✅
✅
3000007304
1e7 viable cells and 2x2mL supernatant
35²
TEM – Ultrastructural Evaluation of Cell Culture Morphology, with Characterization and Tabulation of Retrovirus-like Particles (GMP)
✅
✅
3000005236
2e7 viable cells
35²
MVM DNA Detection by qPCR using TaqMan (GMP)
✅
✅
3000005740
1e7 cells frozen
12
9 CFR Porcine Viruses Detection – 21 day (GMP)3
✅
✅
3000007387
1x500mL serum or 2x8mL cell lysate
31
9 CFR Bovine Viruses Detection in Bovine Serum or Other Products – 21 day (GMP)3
✅
✅
3000007314
1x500mL serum or 2x8mL cell lysate
31
Discriminatory Detection of PCV 1 and PCV 2 by qPCR using TaqMan – Automated (GMP)3
✅
✅
3000005134
1e7 cell pellet or suspension
12
BPyV DNA Detection by qPCR using Taqman (GMP)3
✅
✅
3000005445
1e7 cells
12
F-PBRT Assay using AMuLV as a Positive Control (GMP)4
✅
3000007535
1mL supernatant
12
Calicivirus RNA Detection by RT-qPCR using TaqMan (GMP)
✅
3000007833
1e7 cells frozen
12
Hamster Antibody Production (HAP) (GMP)
✅
3000007683
1x5mL & 10e7 cells/mL
65
Mouse Antibody Production (MAP) (GMP)
✅
3000007681
1x8mL & 10e7 cells/mL
65
Identity
Non-Human Cell Line Identity using Ion Torrent Genexus Sequencers – CHO (GMP)
✅
✅
✅
3000004958
1e6 cells
10
Stability
Sanger Sequencing of Genomic DNA for Targeted Region (GMP)
✅
✅
3000007779
5e6 cells
18
Determination of Genetic Stability by Gene Copy Number Analysis Using TaqMan (GMP)
✅
✅
Varies⁵
2e7-6e7 frozen cell suspension or pellet
21
DNA Restriction Enzyme Digest Analysis (Southern Blot) Utilizing Chemiluminescence Detection (GMP)
✅
✅
Varies⁵
2e7-6e7 frozen cell suspension or pellet
21

Regulatory Expectations

  • For CHO-based MCB, WCB, and EOP/Limit of In Vitro Cell Age (LIVCA) characterization, ICH Q5B, ICH Q5D and ICH Q5A(R2) serve as the primary global standards, supplemented by regional guidance (FDA, EMA) and WHO recommendations.

    These documents collectively define expectations for:

    • Cell substrate characterization
    • Viral safety
    • Expression construct analysis

    Referencing these guidelines ensures alignment with current global regulatory expectations for biologics manufactured in CHO cells.

Requirements for Different Stages of Cell Banking

  • Testing requirements should be risk based and lifecycle appropriate. The MCB is the foundational cell substrate and therefore requires the most extensive and comprehensive testing including identity, purity, genetic, and cell characterization. The WCB is derived from the MCB and requires a reduced, confirmatory testing panel to confirm that it is derived from the qualified MCB, that no contamination occurred during expansion, and key characteristics remain unchanged.

  • Finally, EOP cells represent the maximum population doubling level or passage number used in manufacturing. The purpose of testing these banks is to demonstrate that the cell line remains genetically and phenotypically stable through the maximum in vitro cell age used for production. Once confirmatory and design studies are completed, Minaris can complete full cell bank characterization.

cGMP Cell Bank Manufacturing

  • In addition to comprehensive cell bank characterization testing, Minaris also manufactures and characterizes cGMP-compliant cell banks to support both clinical and commercial programs. With more than 20 years of experience in cell bank manufacturing, integrated services include cell expansion, harvest and fill, and cryopreservation using controlled-rate freezers. Banks are delivered fully released, characterized, and ready for use. Minaris provides a dedicated program manager, the same highly trained team from verification run to manufacturing, flexible shift models to support variable expansion and doubling times, and daily readouts and full transparency throughout your program.

Get in Touch With Our Team Today

Ready to discuss your CHO cell bank characterization needs? Our team is here to help.